- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/765 - Serum albumin, e.g. HSA
Patent holdings for IPC class C07K 14/765
Total number of patents in this class: 664
10-year publication summary
|
51
|
60
|
51
|
60
|
47
|
69
|
49
|
61
|
47
|
30
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| JCR Pharmaceuticals Co., Ltd. | 230 |
16 |
| Bristol-myers Squibb Company | 4729 |
15 |
| Sartorius Albumedix Limited | 49 |
15 |
| Wuhan Healthgen Biotechnology Corp | 29 |
10 |
| MedImmune, LLC | 497 |
9 |
| Novozymes Biopharma DK A/S | 25 |
9 |
| Sanofi Aatd Inc. | 17 |
9 |
| Tonghua Anrate Biopharmaceutical Co., Ltd | 17 |
8 |
| Janssen Biotech, Inc. | 1762 |
7 |
| Silver Creek Pharmaceuticals, Inc. | 31 |
7 |
| Shenzhen Protgen Ltd. | 10 |
7 |
| CSL Limited | 246 |
6 |
| Glytech, Inc. | 62 |
6 |
| Healthgen Biotechnology Co., Ltd. | 6 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
6 |
| University of Oslo | 44 |
6 |
| The General Hospital Corporation | 4858 |
5 |
| Molecular Partners AG | 107 |
5 |
| National Research Council of Canada | 1551 |
5 |
| Zymeworks Inc. | 253 |
5 |
| Other owners | 502 |